Barbiturate Drug Market Forecast by Long-acting Barbiturate and Short-acting Barbiturate from 2024 to 2034

<p>In the recently revised research report made by FMI, the <strong>barbiturate drug market</strong> is expected to record US$ 492.8 million in 2024. Certain patient demographics and treatment patterns in various geographies are inducing the use of barbiturate drugs. Additionally, the rising availability of barbiturate medications for neurological disorders is also propelling expansion.</p><table> <tbody> <tr> <th scope='row'>Attributes</th> <td>Key Insights</td> </tr> <tr> <th scope='row'>Industry Size (2024E)</th> <td>US$ 492.8 million</td> </tr> <tr> <th scope='row'>industry Valuation (2034F)</th> <td>US$ 675.0 million</td> </tr> <tr> <th scope='row'>Value-based CAGR (2024 to 2034)</th> <td>3.20%</td> </tr> </tbody></table><p>Category-wise Barbiturate Drug Market Analysis</p><table> <tbody> <tr> <th scope='row'>Leading Drug Type</th> <td>Long-acting Barbiturate</td> </tr> <tr> <th scope='row'>Growth Rate (From 2024 to 2034)</th> <td>3.0%</td> </tr> </tbody></table><table> <tbody> <tr> <th scope='row'>Leading Application</th> <td>Epilepsy</td> </tr> <tr> <th scope='row'>Growth Rate (From 2024 to 2034)</th> <td>2.80%</td> </tr> </tbody></table><p>Barbiturate Drug Market Demand Analysis by Country</p><table> <tbody> <tr> <th scope='row'>Countries</th> <td>Forecast CAGR (2024 to 2034)</td> </tr> <tr> <th scope='row'>The United States</th> <td>3.50%</td> </tr> <tr> <th scope='row'>The United Kingdom</th> <td>4.40%</td> </tr> <tr> <th scope='row'>China</th> <td>3.90%</td> </tr> <tr> <th scope='row'>Japan</th> <td>4.90%</td> </tr> <tr> <th scope='row'>South Korea</th> <td>5.30%</td> </tr> </tbody></table>

<p>在近期由FMI修订的研究报告中，预计至2024年，巴比妥类药物市场将达到4.928亿美元的规模。特定患者人口统计学特征以及不同地理区域的诊疗模式，正推动巴比妥类药物的使用。此外，神经性疾病治疗中巴比妥类药物的日益普及，亦助力市场扩张。</p><table> <tbody> <tr> <th scope='row'>属性</th> <td>关键洞察</td> </tr> <tr> <th scope='row'>行业规模（预计2024年）</th> <td>4.928亿美元</td> </tr> <tr> <th scope='row'>行业估值（预测2034年）</th> <td>6.75亿美元</td> </tr> <tr> <th scope='row'>基于价值的复合年增长率（2024年至2034年）</th> <td>3.20%</td> </tr> </tbody></table><p>按类别划分的巴比妥类药物市场分析</p><table> <tbody> <tr> <th scope='row'>主要药物类型</th> <td>长效巴比妥类药物</td> </tr> <tr> <th scope='row'>增长率（2024年至2034年）</th> <td>3.0%</td> </tr> </tbody></table><table> <tbody> <tr> <th scope='row'>主要应用</th> <td>癫痫</td> </tr> <tr> <th scope='row'>增长率（2024年至2034年）</th> <td>2.80%</td> </tr> </tbody></table><p>按国家划分的巴比妥类药物市场需求分析</p><table> <tbody> <tr> <th scope='row'>国家</th> <td>预测复合年增长率（2024年至2034年）</td> </tr> <tr> <th scope='row'>美国</th> <td>3.50%</td> </tr> <tr> <th scope='row'>英国</th> <td>4.40%</td> </tr> <tr> <th scope='row'>中国</th> <td>3.90%</td> </tr> <tr> <th scope='row'>日本</th> <td>4.90%</td> </tr> <tr> <th scope='row'>韩国</th> <td>5.30%</td> </tr> </tbody></table>